Watching X4 Shares; Zacks Small Cap Research Sets $4.50 Valutaion
Portfolio Pulse from Benzinga Newsdesk
Zacks Small Cap Research has set a valuation of $4.50 for X4 Pharmaceuticals' shares.
August 15, 2023 | 6:03 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
X4 Pharmaceuticals' shares have been valued at $4.50 by Zacks Small Cap Research.
The valuation set by Zacks Small Cap Research could influence investors' perception of X4 Pharmaceuticals' stock value. However, it's uncertain whether this will lead to an increase or decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100